"Erythema Multiforme" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic "bull's-eye" lesions usually occurring on the dorsal aspect of the hands and forearms.
Descriptor ID |
D004892
|
MeSH Number(s) |
C17.800.229.400 C17.800.865.475
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Erythema Multiforme".
Below are MeSH descriptors whose meaning is more specific than "Erythema Multiforme".
This graph shows the total number of publications written about "Erythema Multiforme" by people in this website by year, and whether "Erythema Multiforme" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Erythema Multiforme" by people in Profiles.
-
Bullous Pemphigoid with Atypical Skin Lesions and Acute Interstitial Nephritis: A Case Report and Focused Literature Review. Am J Case Rep. 2019 Feb 18; 20:212-218.
-
Erythema multiforme-like presentation of chronic graft versus host disease. J Am Acad Dermatol. 2008 Nov; 59(5 Suppl):S127-8.
-
Dapsone in the treatment of persistent erythema multiforme. J Drugs Dermatol. 2006 Apr; 5(4):375-6.
-
Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP). Int J Radiat Oncol Biol Phys. 2004 Sep 01; 60(1):302-9.
-
Disseminated vaccinia false alarm. Pediatr Infect Dis J. 2003 Oct; 22(10):925-6.
-
Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol. 1995 May; 104(5):744-9.